Becton, Dickinson and Company
NYSEBDX short interest surges 24% in one week to 3.9% of float, reaching 11.1M shares as of Sept. 10—highest level since late July. Stock down 6% weekly despite analyst targets averaging $196, signaling bearish conviction amid Healthcare sector headwinds.
Becton, Dickinson and Company sits at an unusual crossroads this week — the stock rallied 14% in a month, the Street is busily lifting targets post-earnings, and the CEO just sold $8 million of shares into the…
Becton, Dickinson and Company has had a decisive week — the August 6 fiscal Q3 print landed well enough to push the stock up 6.8% on the week to $176.86, and the Street moved quickly to reprice its targets upward. The…
Snapshot as of 20 Sept 2026
Becton, Dickinson and Company reports its fiscal third-quarter results on August 6 with the stock recovering sharply — up 9.4% over the past month to $165.62 — yet still nursing a 14% year-to-date decline that keeps…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BDX — free to start on ORTEX.
Sign up for free →Open BDX on ORTEX